| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 174,521 | 185,597 | 199,063 | 216,069 | | Cost of Revenue | 15,199 | 93,210 | 103,311 | 113,148 | | | Gross Profit | 159,322 | 92,387 | 95,752 | 102,921 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 105,567 | 30,952 | 35,644 | 41,167 | | Non Recurring | (97) | 4,927 | 488 | 83,645 | | Others | 2,039 | 2,038 | 2,147 | 2,196 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 51,813 | 54,470 | 57,473 | (24,087) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 35 | 11 | 259 | (3,335) | | Earnings Before Interest And Taxes | 51,848 | 54,481 | 57,732 | (27,422) | | Interest Expense | 5,067 | 5,100 | 4,291 | 1,381 | | Income Before Tax | 46,781 | 49,381 | 53,441 | (28,803) | | Income Tax Expense | 16,914 | 17,896 | 20,944 | (56,107) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 29,867 | 31,485 | 32,497 | 27,304 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (68) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 29,867 | 31,485 | 32,497 | 27,236 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $29,867 | $31,485 | $32,497 | $27,236 |
|
0.17% Nasdaq 
Income Statement
